MBRX Stock Posts

MBRX Moleculin Biotech3.57+0.30+9.2%

Premarket:3.00-0.57 (-16.0%)

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

Globe NewswireTue, 30-Jun 8:30 AM

MBRX Moleculin Biotech4.69+0.19+4.2%

Premarket:4.14-0.55 (-11.7%)

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

Globe NewswireWed, 17-Dec 8:31 AM

MBRX Moleculin Biotech6.39+1.69+36.0%

Premarket:5.45-0.94 (-14.7%)

Moleculin Announces Proposed Underwritten Public Offering

PRNewswireTue, 2-Feb 4:22 PM

MBRX Moleculin Biotech4.70-0.27-5.5%

Premarket:7.42+2.72 (+57.9%)

Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model

PRNewswireTue, 2-Feb 7:30 AM

MBRX Moleculin Biotech Inc.0.560.000.0%

Premarket:1.09+0.53 (+93.6%)

Moleculin Announces Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100%

PRNewswireWed, 8-Apr 7:30 AM